Class III

Drug Recall: Digoxin Tablets, USP 62.5 mcg (0.0625 mg), 100-count bottles, Rx Only, Manufactured by: Novitium Pharma LLC, 70 Lake Drive, East Windsor, New Jersey 08520, NDC 70954-200-10

Novitium Pharma LLC · March 25, 2024

Reason for Recall

Failed Impurities/Degradation Specifications

Distribution

U.S. Nationwide

States Affected

NATIONWIDE

Quantity Affected

1,003 bottles

Source: FDA (openFDA Drug Enforcement)

Recall number: D-0443-2024

Status: terminated

SafeCheck provides drug interaction information from FDA-approved product labeling (openFDA). This is for informational purposes only and is not medical advice. Always consult your healthcare provider before making medication decisions.